Samples of lethal drugs contained irregularities, govt agency says

Irregularities have been found in some samples of the drug linked to six deaths in eastern China, the State Food and Drug Administration (SFDA) said yesterday in a statement on its website.

Between May 22 and May 28, six people died at the No 2 Hospital affiliated with Nanchang University in Jiangxi province, after being injected with immune globulin, which is derived from blood plasma, the Xinhua News Agency reported yesterday.

The drug is widely used to enhance the immunity of critically ill patients, such as those suffering from cancer.